Astrana Health (NASDAQ:ASTH) Sets New 1-Year Low – Should You Sell?

Astrana Health, Inc. (NASDAQ:ASTH) hit a new 52-week low during trading on Friday . The stock traded as low as $32.54 and last traded at $32.83, with a volume of 53825 shares trading hands. The stock had previously closed at $33.53.

Wall Street Analyst Weigh In

Several analysts have recently commented on ASTH shares. Macquarie raised shares of Astrana Health to a “hold” rating in a report on Monday, December 16th. KeyCorp initiated coverage on Astrana Health in a research report on Friday, October 11th. They issued a “sector weight” rating for the company. TD Cowen started coverage on shares of Astrana Health in a research report on Monday, October 14th. They set a “buy” rating and a $66.00 price target on the stock. BTIG Research lifted their target price on shares of Astrana Health from $60.00 to $70.00 and gave the stock a “buy” rating in a research note on Thursday, October 3rd. Finally, Robert W. Baird lifted their target price on Astrana Health from $67.00 to $86.00 and gave the company an “outperform” rating in a research report on Wednesday, November 13th. Two investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $65.17.

Astrana Health Trading Down 3.1 %

The business’s fifty day simple moving average is $45.01 and its two-hundred day simple moving average is $47.61. The company has a market cap of $1.83 billion, a price-to-earnings ratio of 25.00, a PEG ratio of 1.80 and a beta of 1.13. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.60.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings data on Thursday, November 7th. The company reported $0.33 EPS for the quarter, meeting analysts’ consensus estimates of $0.33. The company had revenue of $478.71 million for the quarter, compared to analyst estimates of $462.01 million. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. During the same period in the previous year, the business posted $0.47 earnings per share. On average, equities analysts predict that Astrana Health, Inc. will post 1.16 EPS for the current year.

Hedge Funds Weigh In On Astrana Health

A number of hedge funds have recently made changes to their positions in ASTH. State Street Corp acquired a new position in shares of Astrana Health in the 3rd quarter valued at about $91,966,000. Geode Capital Management LLC acquired a new position in Astrana Health during the third quarter valued at approximately $58,995,000. FMR LLC purchased a new stake in Astrana Health during the third quarter worth approximately $48,413,000. SteelPeak Wealth LLC purchased a new position in shares of Astrana Health in the 3rd quarter valued at $39,398,000. Finally, Loomis Sayles & Co. L P acquired a new position in shares of Astrana Health during the 3rd quarter valued at $30,251,000. Institutional investors and hedge funds own 52.77% of the company’s stock.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.